Jilin Aodong Pharmaceutical Group Co Ltd (000623.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000000719

Price
16.73 CNY
Market cap
20.01 bn CNY
P/E (2025)
8.35
P/S (2025)
8.57
Dividend yield
2.99 %
Net margin
102.57 %
Return on equity (ROE)
7.81 %
Return on assets (ROA)
6.96 %

Jilin Aodong Pharmaceutical Group Co Ltd financials

Fiscal year20242025
Revenue2.61 bn CNY2.34 bn CNY
Gross profit1.01 bn CNY1.13 bn CNY
Operating income1.50 bn CNY-62.86 m CNY
EBIT-160.40 m CNY2.47 bn CNY
Net income1.55 bn CNY2.40 bn CNY
Diluted EPS – continuing operations1.32 CNY2.00 CNY

Full history since 1993, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Jilin Aodong Pharmaceutical Group Co Ltd

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Dunhua, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.